James L. Barker

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

Olfactory neuroblastoma: The 22-year experience at one comprehensive cancer center

Eduardo Díaz, Richard H. Johnigan, Colin D. Pero et al. · Head & Neck · 2005 · 198 citations

Neuro-oncology, Surgical Oncology, Tumoral Pathology +15

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 188 citations · Full text

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra et al. · The Lancet Neurology · 2019 · 88 citations · Full text

Elevated pro-inflammatory CD4 ⁺ CD28 ⁻ lymphocytes and stroke recurrence and death

Zurab Nadareishvili, H. Li, Violet Wright et al. · Neurology · 2004 · 83 citations